CAR-T Long Term Follow Up Study
Not Applicable
Recruiting
- Conditions
- Any patients have received a Novartis or Penn CAR-T therapy
- Registration Number
- JPRN-jRCT1080225004
- Lead Sponsor
- ovartis Pharma. K.K.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- recruiting
- Sex
- All
- Target Recruitment
- 14
Inclusion Criteria
All patients who have received a CAR-T therapy and completed or discontinued early from a Novartis sponsored treatment protocol that utilized CAR-T cells or from any CAR-T trial sponsored by the University of Pennsylvania with which Novartis has a contractual agreement to co-develop the CAR technology.
Patients who have provided informed consent for the long term follow up study prior to their study participation.
Exclusion Criteria
There are no specific exclusion criteria for this study.
Study & Design
- Study Type
- Other
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safety<br>Delayed AEs that are suspected to be related to previous CAR T-cell therapy
- Secondary Outcome Measures
Name Time Method